Clinical Trials Directory

Trials / Unknown

UnknownNCT04493918

Effectivity of Mesenchymal Stem Cell on Vertebral Bone Defect Due to Mycobaterium Tuberculosis Infection

Effectivity of Local Implantation of the Mesenchymal Stem Cell on Vertebral Bone Defect Due to Mycobaterium Tuberculosis Infection (Clinical Trial)

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Ahmad Jabir Rahyussalim · Academic / Other
Sex
All
Age
15 Years – 64 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the effectiveness of locally implantation of mesenchymal stem cell on vertebral bone defects due to infection of mycobacterium tuberculosis. there are controlled participants who receives placebo and patients who receives implantation of MSc

Detailed description

Mesenchymal Stem Cell are implanted in Spinal Tuberculosis patient. MSC has inflammatory effect and the ability to form into new bone. In Spinal Tuberculosis, the spread of bacteria is commonly hematogenous, where the focus of infection is at the anterior part of the vertebrae near the subchondral bone. The infection process continues, where the necrotic casseous fragments formed into local abcess that may spread to the sorrounding area. Patient with spinal tuberculosis who receives Anti TB Drug, is planned to undergo debridement, spinal stabilization. After thorough debridement, patient who fall into control group receives normal saline injection, patients who fall into treatment group will receive Mesenchymal Stem Cell.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTMesenchymal Stem cell + Nacl 0.9%Patient who undergo surgery, debridement, decompression and posterior stabilization injection with Nacl 0.9% 2 ml + MSC 30 million unit
COMBINATION_PRODUCTNaCl 0.9%Patient who undergo surgery, debridement, decompression and posterior stabilization injection with Nacl 0.9% 2 ml

Timeline

Start date
2017-05-21
Primary completion
2020-12-30
Completion
2020-12-30
First posted
2020-07-30
Last updated
2020-08-03

Locations

1 site across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT04493918. Inclusion in this directory is not an endorsement.